Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CPAP and Acetazolamide for OSA at Altitude
NCT00928655Phase 4Completed
- Sponsor
- University of Zurich
- Start
- Jun 2009
- Primary completion
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in obstructive sleep apnea syndrome (OSAS) comparing Acetazolamide + CPAP with Placebo + CPAP (2 arms). Primary endpoints: Apnea-Hypopnea Index at Day 3 and Oxygen Saturation at Day 3. Started Jun 2009; status: completed.
02
Drugs
acetazolamide
03
Conditions
obstructive sleep apnea syndrome (OSAS)
Beyond the preview
Go deeper on NCT00928655.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00928655.